C-Protect
Natural health product licensed in Canada
- Licence holder
- Canadian Protein
- NPN or DIN-HM
- 80082304
- Status
- Active licence
- Licence date
- 10 January 2018
- Revision date
- 22 January 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 500 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C | 125 milligramme | 500,000 µg |
| L-Glutathione Source : Glutathione | 185.75 milligramme | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 75 milligramme | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 25 milligramme | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 37.5 milligramme | Not calculated |
| Lycopène Source : Solanum lycopersicum - Chair (fruit) | 7.5 milligramme | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 100 Unités internationales | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Provides antioxidants for the maintenance of good health. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in wound healing. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Source of/An antioxidant that helps to reduce free radicals and lipid oxidation in body tissues. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps to maintain immune function. _Helps to maintain the body's ability to metabolize nutrients._ Source of/An antioxidant that protects the fat in body tissues from oxidation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of serious low blood sugar). Consult a health care practitioner prior to use if you are taking blood pressure medication. Consult a health care practitioner prior to use if you are taking blood thinners. If you are taking prescription medication, consult a healthcare practitioner prior to use as resveratrol may alter the effectiveness of these medications.
Source
Official Health Canada record, licence 80082304
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging